baber/WOPTO huggingface dataset:
Patent AU-1767997-A (AU)
Title: Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
Inventor: MEULEMANS ANN LOUISE GABRIELLE
IPC: A61P1/00
Filed: 1997-02-07
Abstract: PCT No. PCT/EP97/00586 Sec. 371 Date Aug. 11, 1998 Sec. 102(e) Date Aug. 11, 1998 PCT Filed Feb. 7, 1997 PCT Pub. No. WO97/29739 PCT Pub. Date Aug. 21, 1997The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical formulations comprising 5HT4-receptor antagonists for alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors, as well as pharmaceutical compositions comprising 5HT4 receptor antagonists and serotonin reuptake inhibitors.
Patent AU-1958399-A (AU)
Title: Fluidising lances and their arrangement
Inventor: FREI ALEXANDRA
IPC: B08B9/093
Filed: 1999-01-21
Abstract: Lances are arranged in groups, each with its own fluid supply. An Independent claim is included for the corresponding method of grouped distribution of pumps and pumping power. Preferred features: There is a common pump (26) and drive, for each group in the tank (1). A suitable pump and drive is provided for each single-lance group. Each lance (10) used in the arrangement, has a pump delivering fluid through its interior, a pump connection and a pump drive. Pump and drive are directly connected to the lance. Direct connection obviates individual couplings. Nozzles and/or screws(s) on the lance, generate flow.
Patent AU-2006600-A (AU)
Title: Working ship
Inventor: POEL HANS VAN DER
IPC: B63B35/00
Filed: 1999-12-23
Abstract: A working ship (1), comprising a hull (2) provided with driving means and a deck (3). The hull (2) is temporarily submersible. The deck (3) is connected to the hull by using connecting means (8) at an adjustable intermediate distance. The working ship (1) is thus adjustable between a floating position in which the deck (3) is located near the hull and a semi-submerged position in which the hull is located substantially below the water surface and the deck (3) is located above the water surface at a distance from the hull.
Patent AU-2033500-A (AU)
Title: Hapten-carrier conjugates for treating and preventing nicotine addiction
Inventor: ENNIFAR SOFIANE
IPC: A61K47/48
Filed: 1999-12-01
Abstract: Novel hapten-carrier conjugates are capable of inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in its native (S)-(-) state, and have good stability properties. The conjugates are useful in formulating vaccines for active immunization, that are used to prevent and treat nicotine addiction. The antibodies raised in response to the nicotine hapten-carrier conjugate are used for passive immunization. These antibodies are administered for prevention and treatment of nicotine addiction.
Patent AU-2048395-A (AU)
Title: Method for introducing sealant into a clearance
Inventor: ROGERS ALAN FOSTER
IPC: F16L55/162
Filed: 1995-06-02
Abstract: Apparatus is provided for introducing sealant into a clearance between a replacement pipe (9) and an existing pipe (36) within which in use the replacement pipe 9 is located. The apparatus comprises a nose-cone (1) having a tubular body (6) for connection to the upstream end (8) of the replacement pipe (9), frangible means (20) in the form of a pop-out plug; pierceable metal foil; plastic film or membrane to seal the bore of the tubular body (6) and at least one non return valve (2) in the form of an elastic ring (2), rubber O-ring (40) or plug (52) and spring assembly (53) to permit the flow of sealant from the bore of the body (6) into the clearance (37) by way of the wall of the body (6) but to resist return-flow from the clearance (37) into the bore. <IMAGE>
Patent AU-2239095-A (AU)
Title: CCK or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
Inventor: AQUINO CHRISTOPHER JOSEPH
IPC: A61K/
Filed: 1995-04-12
Abstract: Compounds of general formula (I) and physiologically salts thereof, processes for their preparation and their use as modulators of the effects of gastrin and CCK.
Patent AU-2253699-A (AU)
Title: 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and uses thereof
Inventor: QUASH GERARD ANTHONY
IPC: C07D295/18
Filed: 1999-03-31
Abstract: 6,8-Dimercapto-octanoic acid derivatives (I) which are 6-S and/or 8-S substituted by 3-methylthiopropanoyl, and their enantiomers, racemates and salts are new. 6,8-Dimercapto-octanoic acid derivatives of formula (I) which are 6-S and/or 8-S substituted by 3-methylthiopropanoyl, and their R and S enantiomers, racemates and salts are new. R = OR3 or NR'R''; R3 = H, alkyl or -(CR3R4)n-NR'R''; n = 1-10; R', R'' = H or alkyl; or NR'R'' = a N-heterocycle optionally substituted by O or N (sic) which are themselves optionally substituted; R3, R4 = H or alkyl; R1, R2 = H, COCH3 or CO(CH2)2SCH3 (i); provided that at least 1 of R1 and R2 is a group of formula (i).
Patent AU-2282395-A (AU)
Title: Nitric oxide donor composition and method for treatment of anal disorders
Inventor: GORFINE STEPHEN R
IPC: A61K31/56
Filed: 1995-04-10
Abstract: A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anaesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spasm, and so forth, by topical application to or proximate the affected area.
Patent AU-2380500-A (AU)
Title: Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
Inventor: MCKEARN JOHN P
IPC: A61K41/00
Filed: 1999-12-22
Abstract: The present invention provides methods to treat neoplasia disorders in a mammal using a combination of radiation and an integrin antagonist.
Patent AU-2437399-A (AU)
Title: Bib having side edges with stress relief means
Inventor: LAMPSON PATRICIA LEE
IPC: A41B13/10
Filed: 1999-03-02
Abstract: A bib having a predisposition for folding or bending to conform to the wearer. The predisposition is provided by slits, notches or other features which selectively reduce the cross sectional area of the bib or otherwise provide a hinge line. Preferably, the slits or notches are symmetric relative to the longitudinal centerline of the bib. The reduced cross section may extend essentially continuously across the lateral width of the bib. If desired, the hinge lines may converge as the bottom edge of the bib is approached. Preferably, the hinge lines converge at a common point which intercepts both the longitudinal centerline and the bottom edge of the bib.
Patent AU-2472884-A (AU)
Title: Ribbon speaker system
Inventor: WALKER GARY ELLIOTT
IPC: H04R7/18
Filed: 1984-02-20
Abstract: A ribbon speaker system comprising a three-element tweeter, midrange and woofer acoustical transducer unit is disclosed. The tweeter transducer consists of a single, elongated, corrugated aluminum ribbon positioned vertically and connected to the top and bottom of a rigid, elongated frame. Electrical connections are provided at the top and bottom to permit current flow along the length of the ribbon. The aluminum ribbon is located between sets of magnets which are designed to provide a shaped magnetic field that provides magnetic centering of the ribbon. Additional electromagnetic containment for the transducer ribbon is provided by electrical current passing through the ribbon which current returns to its source by means of flat ribbon conductors located on the surfaces of the magnet sets. 
<??>The midrange transducer consists of a single elongated corrugated aluminum ribbon positioned vertically and connected to an elongated frame similar to the tweeter transducer. However, unlike the tweeter transducer, the edges of the midrange ribbon are acoustically sealed to the frame by foam strips. In addition, desired dynamic properties of the ribbon are achieved by fabricating the aluminum ribbon with corrugations that extend at variable slant angles relative to the longitudinal axis of the ribbon. 
<??>The woofer acoustical transducer consists of an elongated, trapezoidal-shaped, corrugated aluminum ribbon that is supported on all sides and mounted vertically in a rigid, elongated frame. To provide a single electrical path through the ribbon it is divided by a series of horizontal cuts into a serpentine pattern. The ribbon is located directly in front of a rectangular array of ceramic magnets mounted on a steel backing sheet.
Patent AU-2476797-A (AU)
Title: Swinging door drive
IPC: E05F15/603
Filed: 1997-06-06
Abstract: Apparatus is are disclosed for selective alteration and control of door movement modes, the apparatus being primarily non-hydraulic and incorporated with a known mechanism which is functional independently from the apparatus in one mode of operation and which includes a piston for controlling door closing characteristics by selected fluid flow within the mechanism. The apparatus includes a motor driven lead screw having a linearly movable shuttle unit mounted thereon, the shuttle unit being positioned relative to the piston of the mechanism to accommodate nonattached contact with the piston to urge the piston, when the shuttle unit is moved, in a direction that will at least provide selective assistance with door opening in another mode of operation.
Patent AU-2587501-A (AU)
Title: Automatic capture verification and afterpotential reduction
Inventor: GRYZWA MARK
IPC: A61N1/37
Filed: 2000-12-20
Abstract: An implantable cardiac rhythm management device capable of automatically detecting intrinsic and evoked response of a patient's heart and suitable for use during capture verification. The device of the present invention may operate in an automatic capture verification mode, wherein an electrocardiogram signal of a patient's heart is received and used by the device to determine whether a stimulation pulse evokes a response by the patient's heart. The device suspends the automatic capture verification mode and/or adjust the detection threshold dependent upon detected and/or measured noise, a determined amplitude of evoked response, a determined modulation in the evoked response, or detected and/or measured artifact. Further, the sensing circuit of the rhythm management device of the present invention reduces afterpotentials that result due to delivery of the stimulation pulses.
Patent AU-2591395-A (AU)
Title: Oligonucleotides with anti-cytomegalovirus activity
Inventor: PARI GREGORY S
IPC: A61K31/70
Filed: 1995-05-19
Abstract: Disclosed are synthetic oligonucleotides 15 to 50 nucleotides in length which are specifically hybridizable with at least a portion of RNA or DNA derived from the UL36, UL84, UL101x-102, or UL112-113 genes of a cytomegalovirus. Also disclosed are pharmaceutical compositions including an oligonucleotide of the invention and methods of inhibiting cytomegalovirus infection using such oligonucleotides.
Patent AU-2605788-A (AU)
Title: Dual liquid cartridge dispenser
Inventor: MALDONADO JOHN E
IPC: A47K5/12
Filed: 1988-10-13
Abstract: The problem with single cartridge dispensers is that when a maintenance person looks at the liquid level of the cartridge, the fluid may be only slightly above the level indicator window with the result that the cartridge would be completely used up before the maintenance person returns to service the dispenser. Thus, it would be desirable to have two cartridges so that the user can completely exhaust one cartridge and then begin dispensing from the second cartridge. The device (10) employs two cartridges (11a,11b) each having a compressable dispensing pump (25a, 25b). A movable compression member (52) is slidable to a first position adjacent the pump (25b) of a first cartridge (11b) or to a second position adjacent the pump (25a) of the second cartridge (11a) so that fluid from only one cartridge may be dispensed at a time.
Patent AU-2632902-A (AU)
Title: Improved hydroprocessing process and method of retrofitting existing hydroprocessing reactors
Inventor: WRISBERG JOHANNES
IPC: C10G65/10
Filed: 2001-11-08
Abstract: The feed admixed with hydrogen gas, is reacted with a catalyst to form a process stream from which gas and liquid streams (12 and 17a,18a) are separated. The liquid stream admixed with hydrogen gas is reacted with another catalyst to obtain another process stream which is mixed with gas stream. An independent claim is included for existing hydroprocessing reactor retrofitting method.
Patent AU-2668084-A (AU)
Title: Preparation of secondary amines
Inventor: TREMPER ALAN WILLIAM
IPC: C07C67/00
Filed: 1984-04-10
Abstract: New intermediates and processes for preparing 6-halo-7,8-dihydroxy-1-(p-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benza zepines involve the reaction of a p-methoxyphenylglyoxal, lower alkyl hemimercaptal with a 2-chloro-3,4-dimethoxyphenethylamine, followed by a borohydride reduction.
Patent AU-2860601-A (AU)
Title: Method for multiple use of a radiotelephone, and radiotelephone system, corresponding subscriber identification module and presence detecting device
Inventor: NOBLINS GERARD
IPC: H04W88/02
Filed: 2000-12-27
Abstract: The invention concerns a method and a system for enabling multiple use of a radiotelephone, also called station, included in a radio communication system. The invention is characterised in that the station can adopt at least the following two operating states, each defined by at least one distinct state parameter: a so-called "mobile station" state, associated with a situation of geographical mobility of the station; and a so-called "fixed station" state, associated with a situation of geographical rigidity of the station within a predetermined fixed site, narrowly delimited in space. Moreover, the inventive method comprises at least a step which consists in a switching over the station, automatically or by user control, based on the presence of the station in a fixed site. The method further consists in at least comparing the position of the station relative to a predetermined fixed site, so as to trigger or validate said at least one state switchover step, if the station effectively shifts from inside outwards of the predetermined fixed site, or inversely.
Patent AU-2866789-A (AU)
Title: 4-substituted-5,6,7,8-tetrahydrobenzo(b)thieno(2,3-b) pyridine-3-carboxylic acid esters
Inventor: FORBES IAN THOMSON
IPC: C07D495/04
Filed: 1989-01-20
Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof: <CHEM>  wherein: R1 is hydrogen, C1-6 alkyl, phenyl or phenyl C1-4 alkyl wherein the phenyl moiety is optionally substituted by one or more C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, hydroxy, C2-7 alkanoyl, halo, trifluoromethyl, nitro, amino optionally substituted by one or two C1-6 alkyl groups or by C2-7 alkanoyl, cyano, carbamoyl or carboxy groups; R2, R3 and R4 are independently selected from hydrogen, C1-6 alkyl, C1-6 alkoxycarbonyl, C1-6 alkylthio, C2-7 alkanoyl, trifluoromethyl, cyano, carbamoyl and carboxy, and phenyl or phenyl C1-4 alkyl in which any phenyl moiety is optionally substituted by C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxycarbonyl, C1-6 alkylthio, hydroxy, C2-7 alkanoyl, chloro, fluoro, trifluoromethyl, nitro or amino optionally substituted by one or two C1-6 alkyl groups or by C2-7 alkanoyl, cyano, carbamoyl and carboxy; R5 and R6 are independently selected from hydrogen, C1-6 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C1-7 alkanoyl, C1-6 alkylsulphonyl, di-(C1-6 alkyl)amino C1-6 alkyl, 3-oxobutyl, 3-hydroxybutyl, phenyl, phenyl C1-4 alkyl, benzoyl, phenyl C2-7 alkanoyl or benzenesulphonyl any of which phenyl moieties are optionally substituted by one or two halogen, C1-6 alkyl, C1-6 alkoxy, CF3, amino or carboxy, or R5 and R6 together are C2-6 polymethylene optionally interrupted by oxygen or NR8 wherein R8 is hydrogen or C1-6 alkyl optionally substituted by hydroxy; and -CO2R7 is a pharmaceutically acceptable ester group, are provided for use in the treatment or prophylaxis of CNS disorders, in particular anxiety or depression.
Patent AU-2955100-A (AU)
Title: System and method for checking fingerprints
Inventor: OBRINK MARTEN
IPC: A61B5/117
Filed: 2000-02-11
Abstract: A system for checking fingerprints comprises a sensor (1) which is adapted to record a fingerprint made by a fingertip. The surface of a sensor is so small that it can record merely a partial fingerprint. This partial fingerprint is compared with different parts of a complete, previously stored reference fingerprint to determine whether the partial fingerprint originates from the same person as the reference fingerprint. A method for carrying out the checking of fingerprints is also disclosed.
Patent AU-3031800-A (AU)
Title: Foamy virus vectors for expressing foreign genes in mammals and the use thereof
Inventor: FLUGEL ROLF-M
IPC: C07K14/15
Filed: 1999-12-17
Abstract: Beschrieben werden retrovirale, auf felinen Foamyviren (FeFV) basierende Vektoren zur Einführung einer gewünschten, exprimierbaren DNA in eine Säugerzelle. Ein Beispiel des erfindungsgemässen Vektors ist ein Vektor, der die Expression von neutralisierenden Epitopen des felinen Immundefizienzvirus (FIV) in der Katze oder des menschlichen Immundefizienzvirus (HIV) im Menschen und damit eine wirksame Vakzinierung erlaubt.
Patent AU-3159301-A (AU)
Title: Hematological assay and reagent
Inventor: GEMPELER PATRIZIA MARIA
IPC: G01N33/48
Filed: 2000-12-14
Abstract: A hematological assay is described in which the blood coagulation potential of a body fluid is assessed by reacting a sample of the body fluid with an amount of an activator reagent comprising: (a) a predetermined amount of factor Xa or a hematologically equivalent mutant thereof, and (b) a predetermined amount of factor Va, a hematologically equivalent mutant thereof or an enzyme activating endogenous factor V, (c) (optionally) phospholipids. The reagent may be dry (e.g. lyophilised) or in an aqueous solution preferably buffered to a pH from 6 to 10 (preferably 7 to 8), if desired incubating, if necessary inducing coagulation by the addition of one or more coagulation accelerants such as calcium chloride, and establishing a value indicative of the coagulation potential, e.g. by measuring the time to clotting on an optical coagulometer or through use of a chromogenic substrate. It is preferred to use at (b) factor V activator from purified Russell's Viper venom (RVV-V). An activator reagent is also described containing the components mentioned above preferably in one or more buffer solutions or in dried, e.g. lyophilised form.
Patent AU-3268995-A (AU)
Title: Layout for radio frequency power transistors
Inventor: JOHANSSON TED
IPC: H01L21/60
Filed: 1995-08-16
Abstract: A layout is provided for RF power transistors that reduces common lead inductance and its associated performance penalties. An RF transistor cell is rotated 90 DEG  with respect to a conventional RF transistor cell so as to located bond pads nearer the edge of a silicon die, reducing bond wire length and common lead inductance and thereby improving performance at high frequencies. The placement of bond pad and distribution of different parts of the transistor layout further reduces common lead inductance.
Patent AU-3378789-A (AU)
Title: Reinforced polymeric component and method of manufacture
IPC: B29D29/08
Filed: 1989-04-27
Abstract: A reinforced belt assembly or construction which utilizes a reinforcing material comprised of a reinforcing member portion possessing a high Young's modulus discontinuous throughout the length of the reinforcing material and a carrier member portion extending the length of the reinforcing material. The carrier member portion facilitates transport and winding of the reinforcing material about a forming mandel during manufacture and facilitates cutting of the belt assembly from the cured reinforced sleeve material such that the Young's modulus member does not emerge from the cut sidewalls of the belt assembly.
Patent AU-3441699-A (AU)
Title: Self-closing cap for the filling neck of a container
Inventor: GILBOA RONNIE
IPC: B60K15/04
Filed: 1999-04-23
Abstract: A self-closing cap for the filling neck of a container, the self-closing cap having integral therewith a smart card having a container coil antenna for communicating with a supply station coil antenna fixed to a supply nozzle when the supply nozzle is inserted into the container through the self-closing cap.
Patent AU-3530289-A (AU)
Title: Synthetic gtf chromium material and process therefor
Inventor: JENSEN NED L
IPC: A61P3/06
Filed: 1989-04-24
Abstract: A novel product obtained by reacting an alkali metal salt of nicotinic acid with a trivalent chromium salt and having glucose tolerance factor activity, a process for its production and a method for its use, are disclosed.
Patent AU-3877297-A (AU)
Title: Vehicle seat
Inventor: IVARSSON TORSTEN
IPC: B60N2/52
Filed: 1997-08-26
Abstract: The present invention relates to a vehicle seat, which can normally move between a lower end position and an upper end position. The seat comprises a bellows for cushioning/dampening movements of the seat in a vertical direction and also a belt reel which together with a belt is capable of locking the position of the seat at an optional height between the end positions.
Patent AU-4118189-A (AU)
Title: Method for producing an article containing a radiation cross-linked polymer and the article produced thereby
Inventor: KISSEL CHARLES L
IPC: D06M15/285
Filed: 1989-09-08
Abstract: A polymer comprising pendant functional groups having the formula   - R1 - @ - CH2X, wherein R1 is a divalent radical and X is selected from organoacyl and cyano, is shaped, for instance by being applied to a substrate, and cross-linked by exposure to radiation having a wavelength in the range of about 10<-><3> to about 400 nm to form an article.
Patent AU-4121785-A (AU)
Title: Antibiotic 6270, process for its production, and its use as an anticoccidiosis agent and a feed additive
Inventor: KUSAKABE YOKO
IPC: A23K10/16
Filed: 1985-04-12
Abstract: An antibiotic 6270 having the following physicochemical properties and a salt thereof:  (1) Colorless needle-like crystals; acidic substance  (2) Melting point: 115 - 118 DEG C  (3) Elementary analysis (Found %):  C: 62.72%, H: 9.49%; O: 27.78%  (4) Specific rotation: [ alpha ]20_D - 11.5 DEG  (C 1.0, methanol)  (5) Ultraviolet absorption spectrum: The maximum absorption bands not observed at 210 nm or more, as measured in the methanol solution (6) Characteristic absorption (cm<-><1>) in the infrared absorption spectrum (taken with the potassium bromide tablet): 3470, 2890, 2945, 2980, 1735, 1460, 1380, 1315, 1165, 1102, 1075, 987, 980 (7) Solubility: Soluble in methanol ethanol, ethyl acetate, chloroform, ether, acetone, and benzene; insoluble in water (8) Color reactions: Positive in the vanilline-sulfuric acid reaction and the Dragendorff reaction; negative in the ninhydrin reaction; colors with I2 gas